Literature DB >> 9743583

Nuclear distribution of human DNA topoisomerase IIbeta: a nuclear targeting signal resides in the 116-residue C-terminal tail.

I G Cowell1, E Willmore, D Chalton, K L Marsh, E Jazrawi, L M Fisher, C A Austin.   

Abstract

We have analyzed the subcellular distribution of the beta isoform of human topoisomerase II using both isoform-specific antisera and an epitope-tagging approach. Previous immunocytochemical studies have yielded differing results with one reporting this isoform to be predominantly nucleolar. Later studies seem to refute this finding, as do our results with isoform-specific antisera reported here. Epitope tagging minimizes potential complications arising from the use of anti-topoisomerase II antisera that may recognize epitopes that are modified or masked in vivo and could lead to misleading results in immunocytochemical studies. A second strength of this approach is that it allowed a comparison with similarly tagged control proteins (derived from the nucleolar transcription factor UBF) that were known to localize unambiguously to the cytoplasmic, nucleoplasmic, or nucleolar compartments. We report that the C-terminal domain of topoisomerase IIbeta fused to a beta-galactosidase tag localizes to the nucleus (but not the nucleolar compartment) and that this is indistinguishable from the localization of native topoisomerase IIbeta detected by isoform-specific antisera. Further analysis revealed that the nuclear localization determinant lies within the 116-residue C-terminal tail of human topoisomerase IIbeta. Copyright 1998 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9743583     DOI: 10.1006/excr.1998.4150

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  10 in total

1.  Nick-forming sequences may be involved in the organization of eukaryotic chromatin into approximately 50 kbp loops.

Authors:  Lóránt Székvölgyi; Eva Hegedüs; Mónika Molnár; Zsolt Bacsó; Krisztina Szarka; Zoltán Beck; Viktor Dombrádi; Caroline Austin; Gábor Szabó
Journal:  Histochem Cell Biol       Date:  2005-09-30       Impact factor: 4.304

2.  Molecular characterization of a nuclear topoisomerase II from Nicotiana tabacum that functionally complements a temperature-sensitive topoisomerase II yeast mutant.

Authors:  B N Singh; Yashwanti Mudgil; S K Sopory; M K Reddy
Journal:  Plant Mol Biol       Date:  2003-07       Impact factor: 4.076

3.  Bioflavonoids as poisons of human topoisomerase II alpha and II beta.

Authors:  Omari J Bandele; Neil Osheroff
Journal:  Biochemistry       Date:  2007-04-26       Impact factor: 3.162

Review 4.  DNA topoisomerase II, genotoxicity, and cancer.

Authors:  A Kathleen McClendon; Neil Osheroff
Journal:  Mutat Res       Date:  2007-07-03       Impact factor: 2.433

5.  Histone deacetylase inhibition redistributes topoisomerase IIβ from heterochromatin to euchromatin.

Authors:  Ian G Cowell; Nikolaos Papageorgiou; Kay Padget; Gary P Watters; Caroline A Austin
Journal:  Nucleus       Date:  2011 Jan-Feb       Impact factor: 4.197

6.  The impact of the human DNA topoisomerase II C-terminal domain on activity.

Authors:  Emma L Meczes; Kathryn L Gilroy; Katherine L West; Caroline A Austin
Journal:  PLoS One       Date:  2008-03-12       Impact factor: 3.240

7.  MRE11 facilitates the removal of human topoisomerase II complexes from genomic DNA.

Authors:  Ka Cheong Lee; Kay Padget; Hannah Curtis; Ian G Cowell; Davide Moiani; Zbyslaw Sondka; Nicholas J Morris; Graham H Jackson; Simon J Cockell; John A Tainer; Caroline A Austin
Journal:  Biol Open       Date:  2012-07-11       Impact factor: 2.422

8.  Nuclear dynamics of topoisomerase IIβ reflects its catalytic activity that is regulated by binding of RNA to the C-terminal domain.

Authors:  Akihisa Onoda; Osamu Hosoya; Kuniaki Sano; Kazuko Kiyama; Hiroshi Kimura; Shinji Kawano; Ryohei Furuta; Mary Miyaji; Ken Tsutsui; Kimiko M Tsutsui
Journal:  Nucleic Acids Res       Date:  2014-07-17       Impact factor: 16.971

9.  Proteasomal inhibition potentiates drugs targeting DNA topoisomerase II.

Authors:  Ka C Lee; Rebecca L Bramley; Ian G Cowell; Graham H Jackson; Caroline A Austin
Journal:  Biochem Pharmacol       Date:  2016-01-12       Impact factor: 5.858

Review 10.  TOP2B: The First Thirty Years.

Authors:  Caroline A Austin; Ka C Lee; Rebecca L Swan; Mushtaq M Khazeem; Catriona M Manville; Peter Cridland; Achim Treumann; Andrew Porter; Nick J Morris; Ian G Cowell
Journal:  Int J Mol Sci       Date:  2018-09-14       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.